stay updated with our newsletter

Search
Close this search box.

Could Cannabidiol Be the Answer to Treatment-resistant Epilepsy & Lennox-Gastaut Syndrome?

The level of frustration and hopelessness is high among one-third of epilepsy cases that are resistant to medication. A just-released study in Lancet, outlines how a pharmaceutical formulation of cannabidiol (20 mg/kg daily), alongside other anti-epilepsy treatments, reduced the number of drop seizures – seizures which involve sudden falls due

Read more

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.